Oral delivery of glutamic acid decarboxylase (GAD)-65 and IL10 by Lactococcus lactis reverses diabetes in recent-onset NOD mice. 2014

Sofie Robert, and Conny Gysemans, and Tatiana Takiishi, and Hannelie Korf, and Isabella Spagnuolo, and Guido Sebastiani, and Karolien Van Huynegem, and Lothar Steidler, and Silvia Caluwaerts, and Pieter Demetter, and Clive H Wasserfall, and Mark A Atkinson, and Francesco Dotta, and Pieter Rottiers, and Tom L Van Belle, and Chantal Mathieu
Clinical and Experimental Endocrinology, Katholieke Universiteit Leuven, Leuven, Belgium.

Growing insight into the pathogenesis of type 1 diabetes (T1D) and numerous studies in preclinical models highlight the potential of antigen-specific approaches to restore tolerance efficiently and safely. Oral administration of protein antigens is a preferred method for tolerance induction, but degradation during gastrointestinal passage can impede such protein-based therapies, reducing their efficacy and making them cost-ineffective. To overcome these limitations, we generated a tolerogenic bacterial delivery technology based on live Lactococcus lactis (LL) bacteria for controlled secretion of the T1D autoantigen GAD65370-575 and the anti-inflammatory cytokine interleukin-10 in the gut. In combination with short-course low-dose anti-CD3, this treatment stabilized insulitis, preserved functional β-cell mass, and restored normoglycemia in recent-onset NOD mice, even when hyperglycemia was severe at diagnosis. Combination therapy did not eliminate pathogenic effector T cells, but increased the presence of functional CD4(+)Foxp3(+)CD25(+) regulatory T cells. These preclinical data indicate a great therapeutic potential of orally administered autoantigen-secreting LL for tolerance induction in T1D.

UI MeSH Term Description Entries
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D005968 Glutamate Decarboxylase A pyridoxal-phosphate protein that catalyzes the alpha-decarboxylation of L-glutamic acid to form gamma-aminobutyric acid and carbon dioxide. The enzyme is found in bacteria and in invertebrate and vertebrate nervous systems. It is the rate-limiting enzyme in determining GAMMA-AMINOBUTYRIC ACID levels in normal nervous tissues. The brain enzyme also acts on L-cysteate, L-cysteine sulfinate, and L-aspartate. EC 4.1.1.15. Glutamate Carboxy-Lyase,Glutamic Acid Decarboxylase,Acid Decarboxylase, Glutamic,Carboxy-Lyase, Glutamate,Decarboxylase, Glutamate,Decarboxylase, Glutamic Acid,Glutamate Carboxy Lyase
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001324 Autoantigens Endogenous tissue constituents with the ability to interact with AUTOANTIBODIES and cause an immune response. Autoantigen,Autologous Antigen,Autologous Antigens,Self-Antigen,Self-Antigens,Antigen, Autologous,Antigens, Autologous,Self Antigen,Self Antigens
D013294 Lactococcus lactis A non-pathogenic species of LACTOCOCCUS found in DAIRY PRODUCTS and responsible for the souring of MILK and the production of LACTIC ACID. Streptococcus lactis,Lactococcus lactis subsp. lactis
D016688 Mice, Inbred NOD A strain of non-obese diabetic mice developed in Japan that has been widely studied as a model for T-cell-dependent autoimmune insulin-dependent diabetes mellitus in which insulitis is a major histopathologic feature, and in which genetic susceptibility is strongly MHC-linked. Non-Obese Diabetic Mice,Mice, NOD,Mouse, Inbred NOD,Mouse, NOD,Non-Obese Diabetic Mouse,Nonobese Diabetic Mice,Nonobese Diabetic Mouse,Diabetic Mice, Non-Obese,Diabetic Mice, Nonobese,Diabetic Mouse, Non-Obese,Diabetic Mouse, Nonobese,Inbred NOD Mice,Inbred NOD Mouse,Mice, Non-Obese Diabetic,Mice, Nonobese Diabetic,Mouse, Non-Obese Diabetic,Mouse, Nonobese Diabetic,NOD Mice,NOD Mice, Inbred,NOD Mouse,NOD Mouse, Inbred,Non Obese Diabetic Mice,Non Obese Diabetic Mouse

Related Publications

Sofie Robert, and Conny Gysemans, and Tatiana Takiishi, and Hannelie Korf, and Isabella Spagnuolo, and Guido Sebastiani, and Karolien Van Huynegem, and Lothar Steidler, and Silvia Caluwaerts, and Pieter Demetter, and Clive H Wasserfall, and Mark A Atkinson, and Francesco Dotta, and Pieter Rottiers, and Tom L Van Belle, and Chantal Mathieu
February 2004, Diabetologia,
Sofie Robert, and Conny Gysemans, and Tatiana Takiishi, and Hannelie Korf, and Isabella Spagnuolo, and Guido Sebastiani, and Karolien Van Huynegem, and Lothar Steidler, and Silvia Caluwaerts, and Pieter Demetter, and Clive H Wasserfall, and Mark A Atkinson, and Francesco Dotta, and Pieter Rottiers, and Tom L Van Belle, and Chantal Mathieu
October 2017, Applied microbiology and biotechnology,
Sofie Robert, and Conny Gysemans, and Tatiana Takiishi, and Hannelie Korf, and Isabella Spagnuolo, and Guido Sebastiani, and Karolien Van Huynegem, and Lothar Steidler, and Silvia Caluwaerts, and Pieter Demetter, and Clive H Wasserfall, and Mark A Atkinson, and Francesco Dotta, and Pieter Rottiers, and Tom L Van Belle, and Chantal Mathieu
July 1995, Clinical immunology and immunopathology,
Sofie Robert, and Conny Gysemans, and Tatiana Takiishi, and Hannelie Korf, and Isabella Spagnuolo, and Guido Sebastiani, and Karolien Van Huynegem, and Lothar Steidler, and Silvia Caluwaerts, and Pieter Demetter, and Clive H Wasserfall, and Mark A Atkinson, and Francesco Dotta, and Pieter Rottiers, and Tom L Van Belle, and Chantal Mathieu
December 1994, Journal of autoimmunity,
Sofie Robert, and Conny Gysemans, and Tatiana Takiishi, and Hannelie Korf, and Isabella Spagnuolo, and Guido Sebastiani, and Karolien Van Huynegem, and Lothar Steidler, and Silvia Caluwaerts, and Pieter Demetter, and Clive H Wasserfall, and Mark A Atkinson, and Francesco Dotta, and Pieter Rottiers, and Tom L Van Belle, and Chantal Mathieu
September 1994, Immunology letters,
Sofie Robert, and Conny Gysemans, and Tatiana Takiishi, and Hannelie Korf, and Isabella Spagnuolo, and Guido Sebastiani, and Karolien Van Huynegem, and Lothar Steidler, and Silvia Caluwaerts, and Pieter Demetter, and Clive H Wasserfall, and Mark A Atkinson, and Francesco Dotta, and Pieter Rottiers, and Tom L Van Belle, and Chantal Mathieu
August 2020, Seizure,
Sofie Robert, and Conny Gysemans, and Tatiana Takiishi, and Hannelie Korf, and Isabella Spagnuolo, and Guido Sebastiani, and Karolien Van Huynegem, and Lothar Steidler, and Silvia Caluwaerts, and Pieter Demetter, and Clive H Wasserfall, and Mark A Atkinson, and Francesco Dotta, and Pieter Rottiers, and Tom L Van Belle, and Chantal Mathieu
May 2017, Diabetic medicine : a journal of the British Diabetic Association,
Sofie Robert, and Conny Gysemans, and Tatiana Takiishi, and Hannelie Korf, and Isabella Spagnuolo, and Guido Sebastiani, and Karolien Van Huynegem, and Lothar Steidler, and Silvia Caluwaerts, and Pieter Demetter, and Clive H Wasserfall, and Mark A Atkinson, and Francesco Dotta, and Pieter Rottiers, and Tom L Van Belle, and Chantal Mathieu
January 1997, Autoimmunity,
Sofie Robert, and Conny Gysemans, and Tatiana Takiishi, and Hannelie Korf, and Isabella Spagnuolo, and Guido Sebastiani, and Karolien Van Huynegem, and Lothar Steidler, and Silvia Caluwaerts, and Pieter Demetter, and Clive H Wasserfall, and Mark A Atkinson, and Francesco Dotta, and Pieter Rottiers, and Tom L Van Belle, and Chantal Mathieu
June 2003, The Journal of experimental medicine,
Sofie Robert, and Conny Gysemans, and Tatiana Takiishi, and Hannelie Korf, and Isabella Spagnuolo, and Guido Sebastiani, and Karolien Van Huynegem, and Lothar Steidler, and Silvia Caluwaerts, and Pieter Demetter, and Clive H Wasserfall, and Mark A Atkinson, and Francesco Dotta, and Pieter Rottiers, and Tom L Van Belle, and Chantal Mathieu
June 2016, Immunology letters,
Copied contents to your clipboard!